Researchers built a head-mounted microLED array that stimulates a monkey's visual cortex at up to a million points across a centimeter of brain. It reliably evoked visual sensations for more than a year.

Electrically prodding the brain is a blunt instrument. When neuroscientists want to activate a spot on the cortex of a monkey, they usually lower a metal electrode and pass current. The catch is that current spreads, and each electrode sits at a fixed location. You get a handful of stimulation points, spaced roughly a millimeter apart, and you are stuck with wherever you put them. For a technology meant to one day feed information into a blind person's visual cortex, that is nowhere near enough resolution.
A team led by Hao Li and colleagues, reported in Neuron, tried a different approach. Instead of electrodes, they used light. They combined light-sensitive proteins called opsins, which make neurons fire when illuminated, with a dense grid of microLEDs. The result is what they call a mesoscale optogenetics system, and it can address up to a million separate pixels across a centimeter-sized patch of primate cortex.
The number that matters here is flexibility. A conventional electrode array offers you a scatter of preset sites. This device turns a stretch of cortex into something closer to a screen, where the experimenter can choose which points to switch on and in what pattern. According to the paper, stimulation from single pixels produced distinct neural responses centered on the matching cortical location. Light one pixel, and the brain responds at the spot underneath it. Light many in a chosen arrangement, and you can paint an arbitrary pattern at high resolution.
That precision is the whole point. The primate visual cortex is not a uniform sheet. It is organized into fine columns that handle different features of what the eyes see, and that structure plays out at the millimeter-and-below scale that older methods could not reach. The authors note their approach could be especially useful for exactly these regions with prominent columnar organization.
To show the system does something an animal actually perceives, the researchers built a head-mounted version aimed at a monkey's primary visual cortex, the first cortical stop for signals from the eyes. Stimulating there evoked phosphenes, the flashes of light that people report when their visual cortex is activated without any light entering the eye. Anyone who has rubbed their eyes and seen sparks has experienced a crude version of the same thing.
The more striking claim is about durability. Phosphenes could be evoked accurately and reliably for more than a year. Longevity is a quiet but serious problem for brain interfaces. Implanted electrodes often provoke scarring and drift, and signals degrade over months. A system that keeps working across a year of use is the kind of result that separates a lab demonstration from something that might eventually reach a patient.
This is animal research, and the leap to people is large. Delivering opsins to human neurons means introducing a foreign protein, usually with a viral vector, which raises safety and immune questions that a monkey study does not settle. The work reports that patterns can be written onto cortex and that phosphenes appear, but it does not show a monkey recognizing shapes or forming a coherent artificial image. Whether a grid of evoked dots can add up to useful sight is a separate and much harder question. The study also centered on visual cortex; how well the method transfers to other brain regions was not the focus here.
Still, the direction is clear. For decades, visual prosthesis research has leaned on electrodes and accepted their coarse resolution as a fixed cost. Swapping current for light, and a few fixed sites for a million addressable ones, changes what is on the table. The engineering that made it possible, brighter and smaller microLEDs plus better opsins, has been maturing for years. This is a sign of what happens when those pieces are finally assembled and pointed at a working brain.
Weekly research updates, breakthrough summaries, and new articles — straight to your inbox. Free, always.
Comments